Hyderabad, Feb. 8

Dr Reddy’s Laboratories Ltd has entered into an agreement with London-based SkyePharma PLC to undertake a feasibility study of a product (which has not been disclosed) utilising two of SkyePharma’s proprietary drug delivery systems. The costs of the study would be borne by the Hyderabad-based pharma major while SkyePharma would also receive an upfront payment. If the feasibility study is successful, full development activities would begin later this year, according to a release.

Our Bureau

(This article was published in the Business Line print edition dated February 9, 2008)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.